Validated Antimicrobial Persistence
2% CHG + 70% IPA formulation maintains broad-spectrum bactericidal activity on human skin for up to 48 hours post-application.
Engineered with 2% Chlorhexidine Gluconate & 70% Isopropyl Alcohol. Validated fast-acting bactericidal efficacy with persistent 48-hour residual protection, manufactured in ISO 13485 & CE MDR certified cleanrooms.
2% CHG + 70% IPA formulation maintains broad-spectrum bactericidal activity on human skin for up to 48 hours post-application.
India's first direct manufacturer of glass-free, pinch/snap activation CHG applicators eliminating sterile field contamination risks.
Comprehensive regulatory technical files, biocompatibility data, and EO sterilization validation ready for worldwide hospital tenders.
In the continuous global effort to eliminate Surgical Site Infections (SSIs) and Catheter-Related Bloodstream Infections (CRBSIs), medical procurement committees worldwide are phasing out traditional Povidone-Iodine (PVP-I) and bulk-liquid antiseptic pour bottles in favor of single-use, pre-dosed CHG Applicators (Chlorhexidine Gluconate in Isopropyl Alcohol).
Unlike aqueous Povidone-Iodine, which is rapidly neutralized by human blood, serum proteins, and organic matter, Chlorhexidine Gluconate binds cationic-to-anionic lipid membranes of microbial cell walls. This irreversible cell wall destruction, combined with 70% Isopropyl Alcohol (IPA) for immediate protein denaturation, yields rapid log-10 reduction of Gram-positive organisms (including Methicillin-Resistant Staphylococcus aureus / MRSA and Vancomycin-Resistant Enterococci / VRE), Gram-negative bacilli, and fungi.
Crucially, CHG exhibits persistent cumulative action. While iodine skin preparations lose antimicrobial activity as soon as they dry or get washed off by wound exudate, CHG remains bound to the stratum corneum, continuing to inhibit microbial re-colonization for up to 48 hours post-prep.
Traditional pour-bottle antiseptics introduce significant operational hazards: inconsistent fluid application, pool-driven chemical burn risks under surgical drapes, lint shedding from cotton gauze balls, and cross-contamination from re-used containers. Modern CHG Applicators integrate an all-in-one hermetically sealed ampoule and specialized open-cell polyurethane foam head.
Pressurizing or snapping the internal ampoule dispenses an exact, validated volume (from 1.5 mL to 26 mL) directly into the sponge material. Friction-based scrubbing forces the antiseptic deep into epidermal folds and skin crevices where 80% of resident microflora reside, ensuring uniform coverage without fluid run-off or waste.
Every clinical site requires precise volume control. Over-saturation creates fluid pooling risks, while under-saturation leaves skin un-prepped. Explore our standardized SKU matrix engineered for specific anatomical preps.
Specifically sized for CVC, PICC line placement, arterial line maintenance, blood culture collection, and minor dermatological excisions. Preps up to 10cm x 10cm surgical area.
Request Sample & Specs →Engineered for medium-area surgical fields including orthopedic extremity surgeries, carotid endarterectomy, head/neck interventions, and laparoscopic port prep. Preps 25cm x 30cm area.
Request Sample & Specs →High-capacity applicator designed for total joint arthroplasty, open cardiac surgery, spinal fusion, and major abdominal procedures. Features ergonomic wing-grip for controlled dose application across 50cm x 50cm surface.
Request Sample & Specs →Ideal for mucosal adjacent zones, surgical wound care, umbilical prep, and pediatric vascular care where controlled directional swabbing is required without excess fluid release.
Request Sample & Specs →Formulated with medical-grade non-toxic dyes that clearly delineate the sterile prep boundary on diverse skin tones, washing off naturally post-procedure without staining.
Request Sample & Specs →Direct OEM integration into Surgeine Custom Procedure Packs (Plavus brand), bundling applicators alongside AAMI Level 4 gowns, sterile surgical drapes, and surgical dressings for streamlined OR setup.
Request Sample & Specs →Compare clinical coverage area, active formulation ratios, package footprint, and sterilization validation across our main CHG applicator configurations.
| Specification Parameter | 1.5 mL / 3.0 mL Applicator | 10.5 mL Applicator | 26.0 mL Applicator | CHG Swab Stick (1.5" & 4") |
|---|---|---|---|---|
| Active Ingredients | 2% Chlorhexidine Gluconate (w/v) + 70% Isopropyl Alcohol (v/v) | 2% Chlorhexidine Gluconate (w/v) + 70% Isopropyl Alcohol (v/v) | 2% Chlorhexidine Gluconate (w/v) + 70% Isopropyl Alcohol (v/v) | 2% Chlorhexidine Gluconate (w/v) + 70% Isopropyl Alcohol (v/v) |
| Approx. Coverage Area | 10 cm × 10 cm (IV / Vascular) | 25 cm × 30 cm (Limb / Neck) | 50 cm × 50 cm (Abdominal / Thoracic) | 5 cm × 10 cm (Targeted Site) |
| Ampoule Mechanism | Glass-Free Pinch Polymeric Capsule | Snap-Lever Precision Internal Ampoule | Dual Wing-Pinch Polymer Mechanism | Squeeze-Sleeve / Pre-saturated Tip |
| Sponge Foam Type | Medical-Grade Polyurethane (Open-Cell, Lint-Free) | High-Density Polyurethane (Abrasion Resistant) | Dual-Layer Polyurethane Matrix (Zero Droplet Drop) | Medical Cotton-Poly Foam Blend |
| Tint Availability | Clear / Hi-Lite Orange | Clear / Hi-Lite Orange / Teal | Clear / Hi-Lite Orange / Teal | Clear / Hi-Lite Orange |
| Sterilization & Packaging | Ethylene Oxide (EO), Medical Tyvek Peel Pouch | Ethylene Oxide (EO), Medical Tyvek Peel Pouch | Ethylene Oxide (EO), Medical Tyvek Peel Pouch | Ethylene Oxide (EO), Multi-Barrier Foil Pouch |
| Shelf Life & Storage | 24 to 36 Months (Store 15°C - 30°C) | 24 to 36 Months (Store 15°C - 30°C) | 24 to 36 Months (Store 15°C - 30°C) | 24 Months (Store 15°C - 30°C) |
| Regulatory Approvals | ISO 13485:2016, CE MDR, BIS, SFDA | ISO 13485:2016, CE MDR, BIS, SFDA | ISO 13485:2016, CE MDR, BIS, SFDA | ISO 13485:2016, CE MDR, BIS, SFDA |
Note: Customized formulation ratios (e.g., 0.5% CHG in 70% IPA or custom dye concentrations) can be formulated for specific international tender specifications. Contact our technical team for custom OEM requests.
First-generation antiseptic applicators relied heavily on internal thin-walled glass ampoules containing liquid CHG/IPA. When clinical personnel squeezed the outer plastic handle, the glass ampoule shattered, allowing the solution to soak into the sponge tip. However, clinical audits revealed two serious defects: micro-glass shard penetration through the sponge into patient surgical sites, and sharp glass puncture through outer handles causing needle-stick-like micro-tears in surgeon gloves.
Surgeine Healthcare pioneered the production of glass-free polymer ampoule mechanisms. Utilizing precision-molded medical-grade polyolefin barriers, our applicators release the active antiseptic solution through a controlled mechanical fracture line or internal valve snap. This completely eliminates glass fragmentation hazards while preserving fluid stability and zero evaporation during long-term storage.
Substandard foam applicators cause flaking, lint detachment, or irregular fluid surge. Surgeine’s internal R&D utilizes custom hydrophilic open-cell polyurethane foam with audited cell density (PPI - Pores Per Inch). This ensures:
Every production lot of Surgeine Dispo Prep applicators undergoes rigorous batch analysis inside our ISO 17025 accredited laboratory:
As healthcare systems navigate post-pandemic supply chain vulnerabilities, regulatory tightening, and cost optimization, hospital purchasing groups (GPOs) and distributors are adapting their sourcing strategies for CHG applicators.
Historically, two major Western conglomerates controlled over 80% of global CHG applicator supply, leading to acute stockouts during logistics disruptions. Global buyers are actively diversifying toward tier-1 certified manufacturers in India like Surgeine, offering redundant supply security without quality compromise.
The transition from EU MDD to EU MDR has forced numerous low-tier manufacturers out of the European market due to rigorous clinical evaluation reports (CER) and strict substance limits. Importers require manufacturers holding direct, verified CE certificates under EU MDR 2017/745.
Procurement departments are reducing individual SKU purchase orders by procuring custom surgical procedure packs that pre-integrate CHG applicators, sterile drapes, and gowns. This minimizes OR opening times by up to 40% and drastically reduces sterile packaging waste.
Hospitals are demanding recyclable Tyvek packaging, ultra-low Ethylene Oxide (EO) sterilization residuals, and non-toxic dye formulations that do not leach harmful volatile organic compounds (VOCs) during OR application.
Evaluating prep solutions solely on unit purchase price is being replaced by TCO models. Preventing a single Deep Surgical Site Infection saves hospitals an average of $25,000 to $40,000 in extended hospital stays; investing in high-grade CHG applicators provides immediate financial ROI.
Regional distributors are increasingly building private-label medical consumable portfolios. Direct factory partners that offer low MOQs, customized branding, multi-language artwork, and regulatory file support are capturing significant market share.
Surgeine Healthcare has maintained a single focus for over two decades: designing and manufacturing medical devices that protect the sterile field. Our multi-facility industrial footprint combines vertical lamination, medical packaging, cleanroom assembly, and in-house microbiological testing under a unified quality management system.
As the first manufacturer in India to produce CHG applicators, swab sticks, and disinfectant caps, Surgeine provides global importers and healthcare providers with uncompromised manufacturing integrity.
Surgeine maintains verified ISO 13485:2016 accreditation and holds CE certification under EU MDR 2017/745 (obtained in 2024, continuing continuous CE compliance maintained since 2008). Additional approvals include SFDA, BIS, and ZED Gold recognition.
Our four manufacturing units feature Class 100,000 (ISO Class 8) and Class 10,000 (ISO Class 7) controlled cleanroom environments, positive pressure air handling (AHU), and automated fluid filling lines to eliminate environmental bioburden during applicator production.
We support global medical brands, GPOs, and regional healthcare distributors with end-to-end OEM services: custom applicator sizing, custom fluid formulation, brand packaging artwork development, and multi-language Instructions for Use (IFU) translation.
Recognized with Star Export House status, Surgeine exports sterile disposables to more than 25 countries across Europe, the Middle East, Latin America, Africa, and Asia, managing seamless freight logistics and customs registration documentation.
When purchasing CHG applicators, regulatory documentation is as vital as physical product quality. Surgeine provides complete technical dossiers for hospital procurement committees and government health tenders.
Our technical files include sterilisation validation protocol summaries, active ingredient assay certificates, stability testing reports, skin sensitization/irritation study data (ISO 10993 biocompatibility), and Certificate of Free Sale (CFS).
CE (EU MDR) Certificate
ISO 13485:2016
ZED Gold Standard
Star Export House
BIS CertifiedOur specialized medical brands address specific stages of surgical care — from preoperative skin prep to surgical drapes, dressing kits, and operating room turnaround.
Dispo Prep (CHG Applicators)
Plavus (Custom Procedure Packs)
Surgeine (Drapes & Gowns)
ClinicaTex (Dressing Kits)
OR Swift (Room Turnaround)Answers to the top regulatory, clinical, and commercial questions asked by hospital infection control managers, B2B procurement leads, and medical device distributors.
Standard Surgeine Dispo Prep applicators contain 2% w/v Chlorhexidine Gluconate (CHG) combined with 70% v/v Isopropyl Alcohol (IPA). This exact concentration ratio is recommended by international clinical evidence guidelines (CDC, WHO, SHEA, AORN, APIC) for optimal fast-acting bactericidal and persistent residual action. Custom ratios (such as 0.5% CHG or 4% CHG aqueous preparations) can also be manufactured for specialized tender requirements.
Multiple randomized clinical trials demonstrate that 2% CHG in 70% IPA reduces surgical site infections by up to 41% compared to Povidone-Iodine. Key operational advantages include: (1) Faster kill rate—70% IPA kills bacteria within 30 seconds; (2) Persistent 48-hour residual activity bound to skin lipids; (3) Retained efficacy in blood and organic fluids, whereas iodine is rapidly inactivated by organic load.
Yes. Surgeine was India's pioneer in transitioning from fragile glass ampoules to advanced glass-free polymer ampoules. Our applicator handles utilize medical-grade polyolefin internal snap/pinch mechanisms. This eliminates any possibility of micro-glass fragments shedding onto the patient's surgical incision site or causing gloved hand punctures during clinical activation.
Selection depends on the anatomical preparation area required:
Our CHG applicators carry a validated shelf life of 24 to 36 months from the date of Ethylene Oxide (EO) sterilization when stored in original unopened medical-grade Tyvek blister pouches between 15°C and 30°C (59°F - 86°F). Accelerating degradation and real-time stability testing reports are available in our technical dossier.
Yes. We offer both clear (transparent) formulations and Hi-Lite tinted variants (medical-grade Hi-Lite Orange or Teal dye). Tinted formulations provide surgeons with an immediate visual confirmation of the prepped skin boundaries across diverse patient skin tones. The dye is biocompatible and washes off post-operatively without permanent staining.
For international market entry and MOH tender submissions, Surgeine provides: (1) ISO 13485:2016 Quality Management Certificate; (2) CE Certification under EU MDR 2017/745; (3) Certificate of Free Sale (CFS); (4) Biocompatibility Test Reports per ISO 10993 (cytotoxicity, sensitization, irritation); (5) EO Sterilization Residual Validation Reports per ISO 11135; (6) HPLC/GC Analytical Test Assay Certificates.
Yes. Surgeine operates dedicated private-label manufacturing programs for medical device distributors, Group Purchasing Organizations (GPOs), and hospital networks. OEM customization options include distributor logo printing on Tyvek peel pouches, custom master carton configurations, custom IFUs in over 15 regional languages, and direct inclusion into custom surgical procedure packs.
Partner directly with India's pioneer manufacturer of CHG applicators and surgical skin preparation disposables. Protect your health system's supply chain with certified ISO 13485 & CE MDR quality, reliable bulk lead times, and competitive direct factory pricing.
Connect with our technical commercial team today for sample evaluation kits, full regulatory technical dossiers, or tender specification matching.
